It was shown that NPM1 inhibition leads to apoptosis and sensitizes NPM1c+‐expressing AML cells to drugs such as ATRA and cytarabine,[30] suggesting that NPM1 is a target for cancer therapy. This evidence concerns the gene NPM1 and acute myeloid leukemia.